149 related articles for article (PubMed ID: 23573544)
21. [Acquisition of atovaquone-proguanil resistance in imported falciparum malaria in a young child].
Aurégan C; Argy N; Hubert V; Aprahamian A; Clain J; Cheron G
Presse Med; 2017 Mar; 46(3):344-346. PubMed ID: 28040348
[No Abstract] [Full Text] [Related]
22. A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax.
Mavrogordato A; Lever AM
J Infect; 2012 Sep; 65(3):269-74. PubMed ID: 22609735
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.
Krudsood S; Patel SN; Tangpukdee N; Thanachartwet W; Leowattana W; Pornpininworakij K; Boggild AK; Looareesuwan S; Kain KC
Am J Trop Med Hyg; 2007 Apr; 76(4):655-8. PubMed ID: 17426165
[TBL] [Abstract][Full Text] [Related]
24. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.
Musset L; Bouchaud O; Matheron S; Massias L; Le Bras J
Microbes Infect; 2006 Sep; 8(11):2599-604. PubMed ID: 16962361
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa.
Lachish T; Bar-Meir M; Eisenberg N; Schwartz E
J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27625401
[TBL] [Abstract][Full Text] [Related]
26. Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis.
Staines HM; Burrow R; Teo BH; Chis Ster I; Kremsner PG; Krishna S
J Antimicrob Chemother; 2018 Mar; 73(3):581-595. PubMed ID: 29237012
[TBL] [Abstract][Full Text] [Related]
27. [What is the value of the combination atovaquone-proguanil for the clinician?].
Delmont J
Med Trop (Mars); 2002; 62(3):232-6. PubMed ID: 12244917
[TBL] [Abstract][Full Text] [Related]
28. Plasmodium falciparum malaria and atovaquone-proguanil treatment failure.
Durand R; Prendki V; Cailhol J; Hubert V; Ralaimazava P; Massias L; Bouchaud O; Le Bras J
Emerg Infect Dis; 2008 Feb; 14(2):320-2. PubMed ID: 18258131
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of malaria chemoprophylaxis against Plasmodium falciparum infection in UK travellers: retrospective observational data.
Zuckerman JN; Batty AJ; Jones ME
Travel Med Infect Dis; 2009 Nov; 7(6):329-36. PubMed ID: 19945009
[TBL] [Abstract][Full Text] [Related]
30. [Post-malaria neurological syndrome complicating a relapse of Plasmodium falciparum malaria after atovaquone-proguanil treatment].
Forestier E; Labe A; Raffenot D; Lecomte C; Rogeaux O
Med Mal Infect; 2011 Jan; 41(1):41-3. PubMed ID: 20800398
[No Abstract] [Full Text] [Related]
31. Atovaquone-proguanil treatment failure in a case of pediatric Plasmodium falciparum infection: Malabsorption and resistance.
L'Huillier AG; Lau R; Bitnun A; Boggild AK
Travel Med Infect Dis; 2020; 37():101829. PubMed ID: 32763494
[No Abstract] [Full Text] [Related]
32. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
Schwartz E; Bujanover S; Kain KC
Clin Infect Dis; 2003 Aug; 37(3):450-1. PubMed ID: 12884171
[TBL] [Abstract][Full Text] [Related]
33. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK
Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852
[TBL] [Abstract][Full Text] [Related]
34. Atovaquone/proguanil for the prophylaxis and treatment of malaria.
Patel SN; Kain KC
Expert Rev Anti Infect Ther; 2005 Dec; 3(6):849-61. PubMed ID: 16307498
[TBL] [Abstract][Full Text] [Related]
35. The conundrum of malaria chemoprophylaxis.
Shanks D
J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27694470
[TBL] [Abstract][Full Text] [Related]
36. [Fluindione and falciparum malaria treated by atovaquone-proguanil].
Kamaliddin C; Joste V; Argy N; Houzé S
Therapie; 2018 Oct; 73(5):445-447. PubMed ID: 29680373
[No Abstract] [Full Text] [Related]
37. Plasmodium falciparum malaria recrudescence occurring 2.5 years after leaving an endemic country.
Berrevoets MA; Sprong T; Meis JF; Dofferhoff AS
Neth J Med; 2013 Oct; 71(8):426-8. PubMed ID: 24127503
[TBL] [Abstract][Full Text] [Related]
38. Selection of Cytochrome
Lin JT; Waltmann A; Moser KA; Park Z; Na YB; Aydemir O; Brazeau NF; Gosi P; Marsh PW; Muller MS; Spring M; Sok S; Bailey JA; Saunders DL; Lon C; Wojnarski M
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33361308
[TBL] [Abstract][Full Text] [Related]
39. Autochthonous falciparum malaria possibly transmitted by luggage-carried vector in Paris, France, February 2013.
Gallien S; Taieb F; Hamane S; De Castro N; Molina JM
Euro Surveill; 2013 Oct; 18(40):. PubMed ID: 24128697
[TBL] [Abstract][Full Text] [Related]
40. Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports.
Färnert A; Lindberg J; Gil P; Swedberg G; Berqvist Y; Thapar MM; Lindegårdh N; Berezcky S; Björkman A
BMJ; 2003 Mar; 326(7390):628-9. PubMed ID: 12649236
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
